Clinical Trial Update: Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a dose-escalation study of Interleukin-7 (IL-7) in combination with Bitherapy in Asian patients with Hepatitis C who are re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Bitherapy
• Interleukin-7 (interleukin-7)

Snippet

Sponsor: Cytheris SA | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: UNKNOWN